CIK 0001774857
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Aardvark Therapeutics, Inc.
Sign in to watch- Ticker
- AARD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 821606367
- Phone
- +1 858-225-7696
- Business address
- 4370 LA JOLLA VILLAGE DRIVE, SUITE 1050, SAN DIEGO, CA, 92122
- 4 Option exercise Chief Executive Officer acquired 17,209 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 1,250,000 shares at $16.00 ($20,000,000)
- 4 Conversion Director acquired 133,364 shares (conversion)
- 4 Conversion 10% owner acquired 2,050,902 shares (conversion)
- 4 Open-market buy Chief Executive Officer bought 16,542 shares at $16.00 ($264,672)
- 4 Open-market buy Chief Financial Officer bought 10,000 shares at $16.00 ($160,000)
- 4 Open-market buy Former 10% Owner bought 187,500 shares at $16.00 ($3,000,000)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 2 of 3 · 46 filings